Heteroaryl piperidine glycine transporter inhibitors

Details for Australian Patent Application No. 2005228133 (hide)

Owner Merck Sharp & Dohme Limited Merck Sharp & Dohme Corp.

Inventors Naylor, Elizabeth; Wisnoski, David D.; Zhao, Zhijian; Lindsley, Craig W.; Blackaby, Wesley; Jennings, Andrew S.; Duggan, Mark E.; Hartman, George D.; Wolkenberg, Scott E.; Hallett, David; Street, Leslie J.; Wang, Yi; Lewis, Richard T.; Leister, William H.

Agent Spruson & Ferguson

Pub. Number AU-B-2005228133

PCT Pub. Number WO2005/094514

Priority 60/555,925 24.03.04 US

Filing date 23 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 8 September 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/094514 Priority application(s): WO2005/094514

13 May 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Limited; Merck Sharp & Dohme Corp.

8 September 2011 Application Accepted

  Published as AU-B-2005228133

19 January 2012 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Limited; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228145-Transdermal delivery device

2005228117-Thoracic impedance monitor and electrode array and method of use